Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 3947057
Paxton R, Kuntz M, Harris RA (1986) Phosphorylation sites and inactivation of branched-chain alpha-ketoacid dehydrogenase isolated from rat heart, bovine kidney, and rabbit liver, kidney, heart, brain, and skeletal muscle. Arch Biochem Biophys 244, 187-201 3947057
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S333-p - BCKDH E1-alpha (rat)
Modsite: TYRIGHHstsDDSSA SwissProt Entrez-Gene
Orthologous residues
BCKDH E1‑alpha (human): S337‑p, BCKDH E1‑alpha (mouse): S334‑p, BCKDH E1‑alpha (rat): S333‑p, BCKDH E1‑alpha (pig): S339‑p
Characterization
Methods used to characterize site in vivo [32P] ATP in vitro, [32P] bio-synthetic labeling, peptide sequencing
Relevant cell lines - cell types - tissues:  heart
Cellular systems studied:  tissue
Species studied:  rat
Enzymes shown to modify site in vitro
Type Enzyme
KINASE BCKDK (human)
Downstream Regulation
Effect of modification (function):  enzymatic activity, inhibited

S343-p - BCKDH E1-alpha (rat)
Modsite: DDSSAyRsVDEVNYW SwissProt Entrez-Gene
Orthologous residues
BCKDH E1‑alpha (human): S347‑p, BCKDH E1‑alpha (mouse): S344‑p, BCKDH E1‑alpha (rat): S343‑p, BCKDH E1‑alpha (pig): S349‑p
Characterization
Methods used to characterize site in vivo [32P] ATP in vitro, [32P] bio-synthetic labeling, peptide sequencing
Relevant cell lines - cell types - tissues:  heart
Cellular systems studied:  tissue
Species studied:  rat
Enzymes shown to modify site in vitro
Type Enzyme
KINASE BCKDK (human)
Downstream Regulation
Effect of modification (function):  enzymatic activity, inhibited